Progressive increase of glucose transporter-3 (GLUT-3) expression in estrogen-induced breast carcinogenesis

Clinical and Translational Oncology

Volumn 15, Issue 1, 2013, Pages 55-64

  Kocdor, M A ^a   Kocdor, H ^a   Pereira, J S ^b   Vanegas, J E ^b   Russo, I H ^b   Russo, J ^b  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

Breast; Cancer; Estrogen; GLUT

Indexed keywords

ESTROGEN; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 12; GLUCOSE TRANSPORTER 3; UNCLASSIFIED DRUG;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOGENESIS; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GLUCOSE TRANSPORT; GLYCOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; BREAST; CELL TRANSFORMATION, NEOPLASTIC; DOWN-REGULATION; ESTRADIOL; FEMALE; GLUCOSE; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; GLUCOSE TRANSPORTER TYPE 3; HUMANS; MICE; MICE, SCID;

EID: 84872425567     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-012-0882-3     Document Type: Article

References (71)

1. Devlin TM (2006) Biological membranes: structure and membrane transport. In: Devlin TM (ed) Textbook of biochemistry, 6th edn. Wiley-Liss, Hoboken, NJ, pp 443-487
2. Lieberman M, Marks AD (2009) Digestion, absorption, and transport of carbohydrates. In: Marks' basic medical biochemistry a clinical approach, 3rd edn. Wolters Kluwer, LWW, Baltimore MD, pp 499-517
3. Warburg O (1956) On the origin of cancer cells. Science 123:309-314
4. Macheda ML, Rogers S, Best JD (2005) Molecular and cellular regulation of glucose transporter (Glut) proteins in cancer. J Cell Physiol 202:654-662
5. Gatenby RA, Gawlinski ET (2003) The glycolytic phenotype in carcinogenesis and tumor invasion: insights through mathematical models. Cancer Res 63:3847-3854
6. Gillies R, Gatenby RA (2007) Hypoxia and adaptive landscapes in the evaluation of carcinogenesis. Cancer Metastasis Rev 26:311-317
7. Warburg O (1956) On respiratory impairment in cancer cells. Science 124:269-270
8. Hennipman A, van Oirschot BA, Smitz J et al (1988) Glycolytic enzyme activities in breast cancer metastasis. Tumour Biol 9:241-248
9. Suganuma N, Segade F, Matsuzu K, Bowden DW (2007) Differential expression of facilitative glucose transporters in normal and tumour kidney tissues. BJU Int 99:1143-1149
10. Medina RA, Owen GI (2002) Glucose transporters: expression, regulation and cancer. Biol Res 35:9-26
11. Rogers S, Macheda ML, Docherty SE et al (2002) Identification of a novel glucose transporter-like protein GLUT-12. Am J Physiol Endocrinol Metab 282:733-738
12. Stackhouse BL, Williams H, Berry P et al (2005) Measurement of Glut-1 expression using tissue microarrays to determine a race specific prognostic marker for breast cancer. Breast Cancer Res Treat 93:247-253
13. Gatenby RA, Smallbone K, Maini PK et al (2007) Cellular adaptations to hypoxia and acidosis during somatic evaluation of breast cancer. Brit J Cancer 97:646-653
14. Robey IF, Stephen RM, Brown KS et al (2008) Regulation of Warburg effect in early-passage breast cancer cells. Neoplasia 10:745-756
15. Fang JS, Gillies RD, Gatenby RA (2008) Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression. Semin Cancer Biol 18:330-337
16. Airley RE, Mobasheri A (2007) Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics. Chemotherapy 53:233-256
17. Ortega AD, Sanchez-Arago M, Giner-Sanchez D et al (2009) Glucose avidity of carcinomas. Cancer Lett 276:125-135
18. Flier JS, Mueckler MM, Usher P, Lodish HF (1987) Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science 235:1492-1495
19. Gillies RJ, Robey I, Gatenby RA (2008) Causes and consequences of increased glucose metabolism of cancers. J Nucl Med 49:24S-42S
20. Semenza GL, Roth PH, Fang HM, Wang GL (1994) Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 269:23757-23763
21. Zhong H, De Marzo AM, Laughner E et al (1999) Overexpression of hypoxia-inducible factor 1 α in common human cancers and their metastasis. Cancer Res 59:5830-5835
22. Robey IF, Lien AD, Welsh SJ et al (2005) Hypoxia inducible factor-1 alpha and the glycolytic phenotype in tumors. Neoplasia 7:324-330
23. Li J, Shi M, Cao Y et al (2006) Knockdown of hypoxia-inducible factor-1α in breast cancer cells results in reduced tumor growth and increased sensitivity to methotrexate. Biochem Biophy Res Commun 342:1341-1351
24. Burgman P, O'Donoghue JA, Humm JL, Ling CC (2001) Hypoxia-induced increases in FDG uptake in MCF 7 cells. J Nucl Med 42:170-175
25. Liao D, Corle C, Seagroves TN, Johnson RS (2007) Hypoxia-inducible factor-1α is a key regulator of metastasis in a transgenic model of cancer initiation and progression. Cancer Res 67:563-572
26. Toniolo PG, Levitz M, Zeleniuch-Jacquotte A et al (1995) A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst 87:190-197
27. Greenlee RT, Murray T, Bolden S, Wingo PA (2000) Cancer statistics. CA Cancer J Clin 50:7-33
28. Lareef MH, Garber J, Russo PA et al (2004) The estrogen antagonist ICI-182-780 does not inhibit the transformation phenotypes induced by 17-β-estradiol and 4-OH estradiol in human breast epithelial cells. Int J Oncol 26:423-429
29. Russo J, Russo IH (2006) The role of estrogen in the initiation of breast cancer. J Steroid Biochem Mol Biol 102:89-96
30. Russo J, Fernandez SV, Russo PA et al (2006) 17-Beta-estradiol induces transformation and tumorigenesis in human breast epithelial cells. FASEB J 20:1622-1634
31. Shekhar MP, Nangia-Makker P, Wolman SR et al (1998) Direct action of estrogen on sequence of progression of human preneoplastic breast disease. Am J Pathol 152:1129-1132
32. Yamaguchi Y (2007) Microenvironmental regulation of estrogen signals in breast cancer. Breast Cancer 14:175-181
33. Neeman M, Degani H (1989) Metabolic studies of estrogen and tamoxifen-treated human breast cancer cells by nuclear magnetic resonance spectroscopy. Cancer Res 49:589-594
34. Rivenzon-Segal D, Boldin-Adamsky S, Seger D et al (2003) Glycolysis and glucose transporter 1 as markers of response to hormonal therapy in breast cancer. Int J Cancer 107:177-182
35. Meneses AM, Medina RA, Kato S et al (2008) Regulation of GLUT 3 and glucose uptake by cAMP signalling pathway in the breast cancer cell line ZR-75. J Cell Physiol 214:110-116
36. Kurebayashi J, Otsuki T, Moriya T, Sonoo H (2001) Hypoxia reduces hormone responsiveness of human breast cancer cells. Jpn J Cancer Res 92:1093-1101
37. Cooper C, Liu GY, Niu YL et al (2004) Intermittent hypoxia induces proteasome-dependent down-regulation of estrogen receptor α in human breast carcinoma. Clin Cancer Res 10:8720-8727
38. Russo J, Balogh GA, Chen J et al (2006) The concept of stem cell in mammary gland and its implication in morphogenesis, cancer and prevention. Front Biosci 11:151-172
39. Russo J, Lareef MH, Balogh G et al (2003) Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells. J Steroid Biochem Mol Biol 87:1-25
40. Russo J, Lareef MH, Tahin Q et al (2002) 17β-Estradiol is carcinogenic in human breast epithelial cells. J Steroid Biochem Mol Biol 80:149-162
41. Huang Y, Fernandez SV, Goodwin S et al (2007) Epithelial to mesenchymal transition in human breast epithelial cells transformed by 17beta-estradiol. Cancer Res 67:11147-11157
42. Miller FR (2000) Xenograft models of premalignant breast disease. J Mammary Gland Biol Neopl 5:379-391
43. Worsham MJ, Pals G, Schouten JP et al (2006) High-resolution mapping of molecular events associated with immortalization, transformation, and progression to breast cancer in MCF10 model. Breast Cancer Res Treat 96:177-186
44. Chen C, Pore N, Behrooz A et al (2001) Regulation of glut1 mRNA by Hypoxia- inducible factor-1. J Biol Chem 276:9519-9525
45. Blancher C, Moore JW, Robertson N, Harris AL (2001) Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1, HIF-2, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3′-kinase/Akt signaling pathway. Cancer Res 61:7349-7355
46. Burnol AF, Leturque A, Loizeau M et al (1990) Glucose transporter expression in rat mammary gland. Biochem J 270:277-279
47. Alo PL, Visca P, Botti C et al (2001) Immunohistochemical expression of human erythrocyte glucose transporter and fatty acid synthase in infiltrating breast carcinomas and adjacent typical/atypical hyperplastic or normal breast tissue. Am J Clin Pathol 116:129-134
48. Nguyen XC, So Y, Chung JH et al (2008) High correlations between primary tumours and loco-regional metastatic lymph nodes in non-small-cell lung cancer with respect to glucose transporter type 1-mediated 2-deoxy-2F18-fluoro-d- glucose uptake. Eur J Cancer 44:692-698
49. Zhou S, Wang S, Wu Q et al (2008) Expression of glucose transporter-1 and -3 in the head and neck carcinoma - the correlation of the expression with the biological behaviors. ORL J Otorhinolaryngol Relat Spec 70:189-194
50. Rogers S, Docherty SE, Slavin JL et al (2005) Differential expression of GLUT12 in breast cancer and normal breast tissue. Cancer Lett 193:225-233
51. Shi J, Simpkins JW (1997) 17 beta-Estradiol modulation of glucose transporter 1 expression in blood-brain barrier. Am J Physiol 272:E1016-E1022
52. Macheda ML, Williams ED, Best JD et al (2003) Expression and localization of Glut1 and Glut 12 glucose transporters in the pregnant and lactating rat mammary gland. Cell Tissue Res 311:91-97
53. Russo J, Lareef H, Tahin Q, Russo IH (2002) Pathways of carcinogenesis and prevention in the human breast. Eur J Cancer 38:S31-S32
54. Russo J, Mailo D, Hu YF et al (2005) Breast differentiation and its implication in cancer prevention. Clin Cancer Res 11:931s-936s
55. Rivenzon-Segal D, Rushkin E, Polak-Charcon S, Degani H (2000) Glucose transporters and transport kinetics in retinoic acid-differentiated T47D human breast cancer cells. Am J Physiol Endocrinol Metab 279:E508-E519
56. Zhao F-Q, Keating AF (2007) Functional properties and genomics of glucose transporters. Curr Genomics 8:113-128
57. Godoy A, Ulloa V, Rodriguez F et al (2006) Differential subcellular distribution of glucose transporters Glut1-6 and Glut9 in human cancer: ultrastructural localization of Glut1 and Glut5 in breast tissues. J Cell Physiol 207:614-627
58. Medina RA, Meneses AM, Vera JC et al (2003) Estrogen and progesterone up-regulate glucose transporter expression in ZR-75-1 human breast cancer cells. Endocrinology 144:4527-4535
59. Medina RA, Meneses AM, Vera JC et al (2004) Differential regulation of glucose transporter expression by estrogen and progesterone in Ishikawa endometrial cancer cells. J Endocrinol 182:467-478
60. Ciardiello F, Tortora G (1998) Interactions between the epidermal growth factor receptor and Type I protein kinase A: biological significance and therapeutic implications. Clin Cancer Res 4:821-828
61. Troyer K, Lee DC (2001) Regulation of mammary gland development and tumorigenesis by the ERBB signalling network. J Mammary Gland Biol Neoplasia 6:7-21
62. Nicholson RI, Hutcheson IR, Harper ME et al (2001) Modulation of epidermal growth factor receptor in endocrine- resistant, oestrogen receptor-positive breast cancer. Endocr Relat Cancer 8:175-182
63. Nicholson RI, Hutcheson IR, Britton JM et al (2005) Growth factor signalling networks in the breast cancer and resistance to endocrine agents: new therapeutic strategies. J Steroid Biochem Mol Biol 93:257-262
64. Murphy L, Cherlet T, Lewis A et al (2003) New insights into estrogen receptor function in human breast cancer. Ann Med 35:614-631
65. Likhite VS, Stossi F, Kim K et al (2006) Kinase-specific phosphorylation of the estrogen receptor changes receptor interactions with ligand, deoxyribonucleic acid, and coregulators associated with alterations in estrogen and tamoxifen activity. Mol Endocrinol 20:3120-3132
66. Lo HW, Hsu SC, Hung MC (2006) EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocation. Breast Cancer Res Treat 95:211-218
67. Peng XH, Karna P, Cao Z et al (2006) Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1α signal pathways increases resistance to apoptosis by up-regulating survivin gene expression. J Biol Chem 281:25903-25914
68. Tortora G, Pepe S, Bianco C et al (1994) The RIα subunit of protein kinase A controls serum dependency and entry into cell cycle of human mammary epithelial cells. Oncogene 9:3233-3240
69. Binder C, Binder L, Marx D et al (1997) Deregulated simultaneous expression of multiple glucose transporter isoforms in malignant cells and tissues. Anticancer Res 17(6):4299-4304
70. Young CD, Lewis AS, Rudolph MC et al (2011) Modulation of glucose transporter1 (Glut1) expression levels alters Mouse mammary tumor cell growth in vitro and in vivo. PLoS One 6(8):e23205
71. Rastogi S, Banerjee S, Chellappan S, Simon GR (2007) Glut-1 antibodies induce growth arrest and apoptosis in human cancer cell lines. Cancer Lett 257:244-251